Randi Elin Gislefoss


    Publications 2020

    Guldvik IJ, Zuber V, Braadland PR, Grytli HH, Ramberg H, Lilleby W, Thiede B, Zucknick M, Saatcioglu F, Gislefoss R, Kvale R, George A, Gronberg H, Wiklund F, Neal DE, Gnanapragasam VJ, Tasken KA, Mills IG (2020)
    Identification and Validation of Leucine-rich alpha-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
    Eur. Urol. Open Sci., 21, 51-60

    Hektoen HH, Robsahm TE, Andreassen BK, Stenehjem JS, Axcrona K, Mondul A, Gislefoss RE (2020)
    Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway
    Cancer Med, 9 (12), 4420-4432
    DOI 10.1002/cam4.3060, PubMed 32319230

    Keller A, Fehlmann T, Backes C, Kern F, Gislefoss R, Langseth H, Rounge TB, Ludwig N, Meese E (2020)
    Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis
    RNA Biol, 17 (10), 1416-1426
    DOI 10.1080/15476286.2020.1771945, PubMed 32456538

    Xie SH, Ness-Jensen E, Langseth H, Gislefoss RE, Mattsson F, Lagergren J (2020)
    Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma
    Int J Cancer, 148 (4), 905-913
    DOI 10.1002/ijc.33285, PubMed 32895915

    Xie SH, Ness-Jensen E, Rabbani S, Langseth H, Gislefoss RE, Mattsson F, Lagergren J (2020)
    Circulating Sex Hormone Levels and Risk of Esophageal Adenocarcinoma in a Prospective Study in Men
    Am J Gastroenterol, 115 (2), 216-223
    DOI 10.14309/ajg.0000000000000446, PubMed 31658123

    Publications 2019

    Rounge TB, Lauritzen M, Erlandsen SE, Langseth H, Holmen OL, Gislefoss RE (2019)
    Ultralow amounts of DNA from long-term archived serum samples produce quality genotypes
    Eur J Hum Genet, 28 (4), 521-524
    DOI 10.1038/s41431-019-0543-x, PubMed 31719661

    Publications 2018

    Bollineni RC, Koehler CJ, Gislefoss RE, Anonsen JH, Thiede B (2018)
    Large-scale intact glycopeptide identification by Mascot database search
    Sci Rep, 8 (1), 2117
    DOI 10.1038/s41598-018-20331-2, PubMed 29391424

    Bollineni RC, Koehler CJ, Gislefoss RE, Anonsen JH, Thiede B (2018)
    Author Correction: Large-scale intact glycopeptide identification by Mascot database search
    Sci Rep, 8 (1), 9771
    DOI 10.1038/s41598-018-28147-w, PubMed 29934554

    Gislefoss RE, Stenehjem JS, Hektoen HH, Andreassen BK, Langseth H, Axcrona K, Weiderpass E, Mondul A, Robsahm TE (2018)
    Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study
    BMJ Open, 8 (3), e019309
    DOI 10.1136/bmjopen-2017-019309, PubMed 29602840

    Perez-Cornago A, Appleby PN, Boeing H, Gil L, Kyrø C, Ricceri F, Murphy N, Trichopoulou A, Tsilidis KK, Khaw KT, Luben RN, Gislefoss RE, Langseth H, Drake I, Sonestedt E, Wallström P, Stattin P, Johansson A, Landberg R, Nilsson LM, Ozasa K, Tamakoshi A, Mikami K, Kubo T, Sawada N et al. (2018)
    Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls
    Int J Cancer, 143 (11), 2677-2686
    DOI 10.1002/ijc.31640, PubMed 29971774

    Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, Trichopoulou A, Gunter MJ, Tsilidis KK, Sánchez MJ, Olsen A, Brenner H, Schöttker B, Perna L, Holleczek B, Knekt P et al. (2018)
    A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk
    Cancer Res, 79 (1), 274-285
    DOI 10.1158/0008-5472.CAN-18-2318, PubMed 30425058

    Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, Männistö S, Metter EJ, Mikami K, Milne RL et al. (2018)
    Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies
    Eur Urol, 74 (5), 585-594
    DOI 10.1016/j.eururo.2018.07.024, PubMed 30077399

    Publications 2017

    Gislefoss RE, Lauritzen M, Langseth H, Mørkrid L (2017)
    Effect of multiple freeze-thaw cycles on selected biochemical serum components
    Clin Chem Lab Med, 55 (7), 967-973
    DOI 10.1515/cclm-2016-0892, PubMed 27987362

    Hjerkind KV, Gislefoss RE, Tretli S, Nystad W, Bjørge T, Engeland A, Meyer HE, Holvik K, Ursin G, Langseth H (2017)
    Cohort Profile Update: The Janus Serum Bank Cohort in Norway
    Int J Epidemiol, 46 (4), 1101-1102f
    DOI 10.1093/ije/dyw302, PubMed 28087783

    Keller A, Rounge T, Backes C, Ludwig N, Gislefoss R, Leidinger P, Langseth H, Meese E (2017)
    Sources to variability in circulating human miRNA signatures
    RNA Biol, 14 (12), 1791-1798
    DOI 10.1080/15476286.2017.1367888, PubMed 28820329

    Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G (2017)
    Cohort Profile: The Janus Serum Bank Cohort in Norway
    Int J Epidemiol, 46 (2), 403-404g
    DOI 10.1093/ije/dyw027, PubMed 27063606

    Publications 2016

    Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R (2016)
    Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
    BMC Cancer, 16 (1), 799
    DOI 10.1186/s12885-016-2832-x, PubMed 27737647

    Faust H, Andersson K, Luostarinen T, Gislefoss RE, Dillner J (2016)
    Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case-Control Study
    Cancer Epidemiol Biomarkers Prev, 25 (4), 721-4
    DOI 10.1158/1055-9965.EPI-15-1290, PubMed 26908428

    Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J (2016)
    Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer
    Acta Oncol, 55 (7), 839-45
    DOI 10.3109/0284186X.2016.1139178, PubMed 26878091

    Price AJ, Travis RC, Appleby PN, Albanes D, Barricarte Gurrea A, Bjørge T, Bueno-de-Mesquita HB, Chen C, Donovan J, Gislefoss R, Goodman G, Gunter M, Hamdy FC, Johansson M, King IB, Kühn T, Männistö S, Martin RM, Meyer K, Neal DE, Neuhouser ML, Nygård O, Stattin P, Tell GS, Trichopoulou A et al. (2016)
    Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls
    Eur Urol, 70 (6), 941-951
    DOI 10.1016/j.eururo.2016.03.029, PubMed 27061263

    Publications 2015

    Gislefoss RE, Langseth H, Bolstad N, Nustad K, Mørkrid L (2015)
    HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank
    Int J Gynecol Cancer, 25 (9), 1608-15
    DOI 10.1097/IGC.0000000000000532, PubMed 26501436

    Rounge TB, Lauritzen M, Langseth H, Enerly E, Lyle R, Gislefoss RE (2015)
    microRNA Biomarker Discovery and High-Throughput DNA Sequencing Are Possible Using Long-term Archived Serum Samples
    Cancer Epidemiol Biomarkers Prev, 24 (9), 1381-7
    DOI 10.1158/1055-9965.EPI-15-0289, PubMed 26108462

    Publications 2014

    Gislefoss RE, Grimsrud TK, Mørkrid L (2014)
    Stability of selected serum hormones and lipids after long-term storage in the Janus Serum Bank
    Clin Biochem, 48 (6), 364-9
    DOI 10.1016/j.clinbiochem.2014.12.006, PubMed 25523301

    Publications 2013

    Andersson K, Luostarinen T, Strand AS, Langseth H, Gislefoss RE, Forslund O, Pawlita M, Waterboer T, Dillner J (2013)
    Prospective study of genital human papillomaviruses and nonmelanoma skin cancer
    Int J Cancer, 133 (8), 1840-5
    DOI 10.1002/ijc.28188, PubMed 23553409

    Publications 2012

    Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J (2012)
    Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer
    Am J Epidemiol, 175 (7), 685-95
    DOI 10.1093/aje/kwr373, PubMed 22419740

    Gislefoss RE, Grimsrud TK, Høie K, Mørkrid L (2012)
    Stability of testosterone measured in male archival serum samples by two different methods
    Scand J Clin Lab Invest, 72 (7), 555-62
    DOI 10.3109/00365513.2012.705888, PubMed 22935045

    Publications 2011

    Hustad S, Eussen S, Midttun Ø, Ulvik A, van de Kant PM, Mørkrid L, Gislefoss R, Ueland PM (2011)
    Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism
    Clin Chem, 58 (2), 402-10
    DOI 10.1373/clinchem.2011.174490, PubMed 22194632

    Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E (2011)
    Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis
    RNA Biol, 8 (3), 506-16
    DOI 10.4161/rna.8.3.14994, PubMed 21558792

    Publications 2010

    Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H (2010)
    Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study
    Br J Cancer, 102 (11), 1665-9
    DOI 10.1038/sj.bjc.6605675, PubMed 20407437

    Gislefoss RE (2010)
    Quality aspects of long-term stored samples: studies in the Janus Serum Bank of Norway
    In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 970, 1 b. (flere pag.)
    BIBSYS 101339895, ISBN 978-82-8072-502-8

    Hannisdal R, Gislefoss RE, Grimsrud TK, Hustad S, Mørkrid L, Ueland PM (2010)
    Analytical recovery of folate and its degradation products in human serum stored at -25 degrees C for up to 29 years
    J Nutr, 140 (3), 522-6
    DOI 10.3945/jn.109.116418, PubMed 20071651

    Publications 2009

    Gislefoss RE, Grimsrud TK, Mørkrid L (2009)
    Stability of selected serum proteins after long-term storage in the Janus Serum Bank
    Clin Chem Lab Med, 47 (5), 596-603
    DOI 10.1515/CCLM.2009.121, PubMed 19290843

    Publications 2008

    Gislefoss RE, Grimsrud TK, Mørkrid L (2008)
    Long-term stability of serum components in the Janus Serum Bank
    Scand J Clin Lab Invest, 68 (5), 402-9
    DOI 10.1080/00365510701809235, PubMed 18752145

    Publications 2007

    Jørgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M (2007)
    Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors
    Ann Rheum Dis, 67 (6), 860-6
    DOI 10.1136/ard.2007.073825, PubMed 17644543

    Lundstig A, Stattin P, Persson K, Sasnauskas K, Viscidi RP, Gislefoss RE, Dillner J (2007)
    No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus
    Int J Cancer, 121 (5), 1098-102
    DOI 10.1002/ijc.22770, PubMed 17471560

    Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyrönen PP, Lenner P, Luostarinen T, Löve A, Ogmundsdóttir H, Stattin P, Tenkanen L, Tryggvadóttir L, Virtamo J, Wadell G, Widell A, Lehtinen M, Dillner J (2007)
    Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers
    Acta Oncol, 46 (3), 286-307
    DOI 10.1080/02841860701203545, PubMed 17450464

    Publications 2006

    Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A (2006)
    Serum cotinine level as predictor of lung cancer risk
    Cancer Epidemiol Biomarkers Prev, 15 (6), 1184-8
    DOI 10.1158/1055-9965.EPI-06-0032, PubMed 16775179

    Publications 2005

    Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M (2005)
    Chlamydial antibodies and risk of prostate cancer
    Cancer Epidemiol Biomarkers Prev, 14 (2), 385-9
    DOI 10.1158/1055-9965.EPI-03-0325, PubMed 15734962

    Tedeschi R, Luostarinen T, De Paoli P, Gislefoss RE, Tenkanen L, Virtamo J, Koskela P, Hallmans G, Lehtinen M, Dillner J (2005)
    Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk
    Br J Cancer, 93 (7), 834-7
    DOI 10.1038/sj.bjc.6602751, PubMed 16136049

    Publications 2004

    Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A (2004)
    BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study
    Br J Cancer, 91 (10), 1829-34
    DOI 10.1038/sj.bjc.6602199, PubMed 15477862

    Ekstrøm PO, Bjørge T, Dørum A, Longva AS, Heintz KM, Warren DJ, Hansen S, Gislefoss RE, Hovig E (2004)
    Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis
    Anal Chem, 76 (15), 4406-9
    DOI 10.1021/ac049788k, PubMed 15283579

    Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM (2004)
    Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort
    Cancer Epidemiol Biomarkers Prev, 13 (12), 2175-80
    PubMed 15598777

    Publications 2003

    Stattin P, Kaaks R, Johansson R, Gislefoss R, Söderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T (2003)
    Plasma leptin is not associated with prostate cancer risk
    Cancer Epidemiol Biomarkers Prev, 12 (5), 474-5
    PubMed 12750247

    Publications 2002

    Bjørge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SØ, Dillner J (2002)
    Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
    Br J Cancer, 87 (1), 61-4
    DOI 10.1038/sj.bjc.6600350, PubMed 12085257

    Publications 1999

    Elgstoen KBP, Gislefoss R, Jellum E (1999)
    Recent advances in the clinical applications of capillary electrophoresis
    Chromatographia, 49 1, S79-S80

    Publications 1998

    Engvig JP, Olsen KE, Gislefoss RE, Sletten K, Wahlström O, Westermark P (1998)
    Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein
    Scand J Immunol, 48 (1), 92-8
    DOI 10.1046/j.1365-3083.1998.00352.x, PubMed 9714416

    Publications 1997

    Dillner J, Lehtinen M, Björge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M (1997)
    Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
    J Natl Cancer Inst, 89 (17), 1293-9
    DOI 10.1093/jnci/89.17.1293, PubMed 9293920

    Jellum E, Dollekamp H, Brunsvig A, Gislefoss R (1997)
    Diagnostic applications of chromatography and capillary electrophoresis
    J Chromatogr B Biomed Sci Appl, 689 (1), 155-64
    DOI 10.1016/s0378-4347(96)00333-7, PubMed 9061490

    Publications 1995

    Gislefoss RE (1995)
    Karakterisering av et Bence Jones protein fra en pasient med myelomaassosiert amyloidose
    [R.E. Gislefoss>, Oslo, 120 s.
    BIBSYS 950495344

    Page visits: 4724